ID

36740

Description

Phase II Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies & Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02025985

Link

https://clinicaltrials.gov/show/NCT02025985

Keywords

Versions (1)
  1. 6/5/19 6/5/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 5, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Ovarian Carcinoma NCT02025985

English

Eligibility Ovarian Carcinoma NCT02025985

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
ovarian, fallopian tube or peritoneal carcinoma: both platinum refractory and platinum resistant patients, who have received ≥ 1 lines of chemotherapy for relapsed disease (i.e., ≥2 lines of chemotherapy in total).
Description

Ovarian Carcinoma | Fallopian Tube Carcinoma | Carcinoma of peritoneum | Patients Unresponsive to Platinum | Patients Resistant to Platinum | Chemotherapy Quantity Recurrent disease

Data type

boolean

Alias
UMLS CUI [1]
C0029925
UMLS CUI [2]
C0238122
UMLS CUI [3]
C0948303
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C0205269
UMLS CUI [4,3]
C0032207
UMLS CUI [5,1]
C0030705
UMLS CUI [5,2]
C0332325
UMLS CUI [5,3]
C0032207
UMLS CUI [6,1]
C0392920
UMLS CUI [6,2]
C1265611
UMLS CUI [6,3]
C0277556
endometrial carcinoma: patients must have received ≥ 1 line of chemotherapy for relapsed or advanced (stage iv, iiic) disease.
Description

Endometrial Carcinoma | Chemotherapy Quantity | Recurrent disease TNM clinical staging | Advanced disease TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1]
C0476089
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C0277556
UMLS CUI [3,2]
C3258246
UMLS CUI [4,1]
C0679246
UMLS CUI [4,2]
C3258246
cervical carcinoma: patients must have received ≥ 1 lines of chemotherapy for relapsed or advanced (stage ivb) disease.
Description

Cervix carcinoma | Chemotherapy Quantity | Recurrent disease | Advanced disease TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1]
C0302592
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C0277556
UMLS CUI [4,1]
C0679246
UMLS CUI [4,2]
C3258246
breast cancer: adenocarcinoma of the breast with metastatic or locally advanced disease not amenable to curative resection or any other curative treatment.
Description

Breast Carcinoma | Breast adenocarcinoma | Neoplasm Metastasis Inappropriate Excision | Advanced disease Locally Inappropriate Excision | Neoplasm Metastasis Inappropriate Curative treatment | Advanced disease Locally Inappropriate Curative treatment

Data type

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0858252
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C0728940
UMLS CUI [4,1]
C0679246
UMLS CUI [4,2]
C1517927
UMLS CUI [4,3]
C1548788
UMLS CUI [4,4]
C0728940
UMLS CUI [5,1]
C0027627
UMLS CUI [5,2]
C1548788
UMLS CUI [5,3]
C1273390
UMLS CUI [6,1]
C0679246
UMLS CUI [6,2]
C1517927
UMLS CUI [6,3]
C1548788
UMLS CUI [6,4]
C1273390
breast cancer: patients must have received ≥ 1 line of endocrine treatment or chemotherapy for metastatic disease as applicable for the respective breast cancer subtype.
Description

Breast Carcinoma | Hormone Therapy Quantity Neoplasm Metastasis | Chemotherapy Quantity Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0027627
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0027627
breast cancer: patient must have either triple negative cancer or be hormone receptor positive (i.e., er+ and/or pr+) and her2 negative.
Description

Breast Carcinoma | Triple Negative Breast Neoplasms | Hormone receptor positive tumor | Oestrogen receptor positive breast cancer | Progesterone receptor positive tumor | HER2 negative carcinoma of breast

Data type

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C3539878
UMLS CUI [3]
C1563119
UMLS CUI [4]
C2938924
UMLS CUI [5]
C1562928
UMLS CUI [6]
C2316304
must have either measurable disease (recist 1.1) or evaluable disease outside irradiated field on ct/mri. a rise in ca-125 or other tumor marker alone is not sufficient.
Description

Measurable Disease | Evaluable Disease | Exception Radiation Field CT | Exception Radiation Field MRI

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1882536
UMLS CUI [3,3]
C0040405
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1882536
UMLS CUI [4,3]
C0024485
ecog performance status of 0-1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of at least 12 weeks.
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
able to swallow and retain oral medication.
Description

Able to swallow Oral medication | Ability Retain Oral medication

Data type

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
UMLS CUI [2,1]
C0085732
UMLS CUI [2,2]
C0333118
UMLS CUI [2,3]
C0175795
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of complete or partial bowel obstruction.
Description

Intestinal Obstruction Complete | Partial bowel obstruction

Data type

boolean

Alias
UMLS CUI [1,1]
C0021843
UMLS CUI [1,2]
C0205197
UMLS CUI [2]
C1328480
gynecological cancer: all non-epithelial cancers of the ovary, fallopian tube, peritoneum, endometrium or cervix as well as neuro-endocrine tumors are excluded.
Description

Malignant Neoplasms Gynecological Without Epithelium | Neuroendocrine Tumors

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0018417
UMLS CUI [1,3]
C0332288
UMLS CUI [1,4]
C0014609
UMLS CUI [2]
C0206754
radiation (except planned or ongoing palliative radiation to bone outside of the region of measurable disease) ≤ 3 weeks prior to c1d1.
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449
chemotherapy, immunotherapy or systemic anticancer therapy ≤ 3 weeks prior to c1d1.
Description

Chemotherapy | Immunotherapy | Cancer treatment Systemic

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083
UMLS CUI [3,1]
C0920425
UMLS CUI [3,2]
C0205373
Back to the top of the page

Similar models

Eligibility Ovarian Carcinoma NCT02025985

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Ovarian Carcinoma | Fallopian Tube Carcinoma | Carcinoma of peritoneum | Patients Unresponsive to Platinum | Patients Resistant to Platinum | Chemotherapy Quantity Recurrent disease
Item
ovarian, fallopian tube or peritoneal carcinoma: both platinum refractory and platinum resistant patients, who have received ≥ 1 lines of chemotherapy for relapsed disease (i.e., ≥2 lines of chemotherapy in total).
boolean
C0029925 (UMLS CUI [1])
C0238122 (UMLS CUI [2])
C0948303 (UMLS CUI [3])
C0030705 (UMLS CUI [4,1])
C0205269 (UMLS CUI [4,2])
C0032207 (UMLS CUI [4,3])
C0030705 (UMLS CUI [5,1])
C0332325 (UMLS CUI [5,2])
C0032207 (UMLS CUI [5,3])
C0392920 (UMLS CUI [6,1])
C1265611 (UMLS CUI [6,2])
C0277556 (UMLS CUI [6,3])
Endometrial Carcinoma | Chemotherapy Quantity | Recurrent disease TNM clinical staging | Advanced disease TNM clinical staging
Item
endometrial carcinoma: patients must have received ≥ 1 line of chemotherapy for relapsed or advanced (stage iv, iiic) disease.
boolean
C0476089 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3,1])
C3258246 (UMLS CUI [3,2])
C0679246 (UMLS CUI [4,1])
C3258246 (UMLS CUI [4,2])
Cervix carcinoma | Chemotherapy Quantity | Recurrent disease | Advanced disease TNM clinical staging
Item
cervical carcinoma: patients must have received ≥ 1 lines of chemotherapy for relapsed or advanced (stage ivb) disease.
boolean
C0302592 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3])
C0679246 (UMLS CUI [4,1])
C3258246 (UMLS CUI [4,2])
Breast Carcinoma | Breast adenocarcinoma | Neoplasm Metastasis Inappropriate Excision | Advanced disease Locally Inappropriate Excision | Neoplasm Metastasis Inappropriate Curative treatment | Advanced disease Locally Inappropriate Curative treatment
Item
breast cancer: adenocarcinoma of the breast with metastatic or locally advanced disease not amenable to curative resection or any other curative treatment.
boolean
C0678222 (UMLS CUI [1])
C0858252 (UMLS CUI [2])
C0027627 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C0728940 (UMLS CUI [3,3])
C0679246 (UMLS CUI [4,1])
C1517927 (UMLS CUI [4,2])
C1548788 (UMLS CUI [4,3])
C0728940 (UMLS CUI [4,4])
C0027627 (UMLS CUI [5,1])
C1548788 (UMLS CUI [5,2])
C1273390 (UMLS CUI [5,3])
C0679246 (UMLS CUI [6,1])
C1517927 (UMLS CUI [6,2])
C1548788 (UMLS CUI [6,3])
C1273390 (UMLS CUI [6,4])
Breast Carcinoma | Hormone Therapy Quantity Neoplasm Metastasis | Chemotherapy Quantity Neoplasm Metastasis
Item
breast cancer: patients must have received ≥ 1 line of endocrine treatment or chemotherapy for metastatic disease as applicable for the respective breast cancer subtype.
boolean
C0678222 (UMLS CUI [1])
C0279025 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0027627 (UMLS CUI [3,3])
Breast Carcinoma | Triple Negative Breast Neoplasms | Hormone receptor positive tumor | Oestrogen receptor positive breast cancer | Progesterone receptor positive tumor | HER2 negative carcinoma of breast
Item
breast cancer: patient must have either triple negative cancer or be hormone receptor positive (i.e., er+ and/or pr+) and her2 negative.
boolean
C0678222 (UMLS CUI [1])
C3539878 (UMLS CUI [2])
C1563119 (UMLS CUI [3])
C2938924 (UMLS CUI [4])
C1562928 (UMLS CUI [5])
C2316304 (UMLS CUI [6])
Measurable Disease | Evaluable Disease | Exception Radiation Field CT | Exception Radiation Field MRI
Item
must have either measurable disease (recist 1.1) or evaluable disease outside irradiated field on ct/mri. a rise in ca-125 or other tumor marker alone is not sufficient.
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1882536 (UMLS CUI [3,2])
C0040405 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1882536 (UMLS CUI [4,2])
C0024485 (UMLS CUI [4,3])
ECOG performance status
Item
ecog performance status of 0-1.
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 12 weeks.
boolean
C0023671 (UMLS CUI [1])
Able to swallow Oral medication | Ability Retain Oral medication
Item
able to swallow and retain oral medication.
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
C0085732 (UMLS CUI [2,1])
C0333118 (UMLS CUI [2,2])
C0175795 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Intestinal Obstruction Complete | Partial bowel obstruction
Item
evidence of complete or partial bowel obstruction.
boolean
C0021843 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1328480 (UMLS CUI [2])
Malignant Neoplasms Gynecological Without Epithelium | Neuroendocrine Tumors
Item
gynecological cancer: all non-epithelial cancers of the ovary, fallopian tube, peritoneum, endometrium or cervix as well as neuro-endocrine tumors are excluded.
boolean
C0006826 (UMLS CUI [1,1])
C0018417 (UMLS CUI [1,2])
C0332288 (UMLS CUI [1,3])
C0014609 (UMLS CUI [1,4])
C0206754 (UMLS CUI [2])
Therapeutic radiology procedure
Item
radiation (except planned or ongoing palliative radiation to bone outside of the region of measurable disease) ≤ 3 weeks prior to c1d1.
boolean
C1522449 (UMLS CUI [1])
Chemotherapy | Immunotherapy | Cancer treatment Systemic
Item
chemotherapy, immunotherapy or systemic anticancer therapy ≤ 3 weeks prior to c1d1.
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
C0920425 (UMLS CUI [3,1])
C0205373 (UMLS CUI [3,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial